| scholarly article | Q13442814 |
| P50 | author | Ronald C. Kessler | Q7364712 |
| P2093 | author name string | Paul E Greenberg | |
| Patricia A Berglund | |||
| Patricia K Corey-Lisle | |||
| Howard G Birnbaum | |||
| Stephanie A Leong | |||
| Sarah W Lowe | |||
| P433 | issue | 12 | |
| P304 | page(s) | 1465-1475 | |
| P577 | publication date | 2003-12-01 | |
| P1433 | published in | The Journal of Clinical Psychiatry | Q7743563 |
| P1476 | title | The economic burden of depression in the United States: how did it change between 1990 and 2000? | |
| P478 | volume | 64 |
| Q46562661 | "Down in the Sewers": Perceptions of Depression and Depression Care Among African American Men. |
| Q43191404 | (S)-(+)-mecamylamine (TC-5214): a neuronal nicotinic receptor modulator enters phase III trials as an adjunct treatment for Major Depressive Disorder (MDD). |
| Q35252115 | A 10-month, open-label evaluation of desvenlafaxine in outpatients with major depressive disorder |
| Q52317047 | A Web- and Mobile-Based Map of Mental Health Resources for Postsecondary Students (Thought Spot): Protocol for an Economic Evaluation. |
| Q27028050 | A brief history of the development of antidepressant drugs: from monoamines to glutamate |
| Q35936893 | A comparison of the direct costs and cost effectiveness of serotonin reuptake inhibitors and associated adverse drug reactions. |
| Q34734589 | A negative regulator of MAP kinase causes depressive behavior |
| Q30951773 | A new clinical rating scale for work absence and productivity: validation in patients with major depressive disorder |
| Q35237120 | A new paradigm for the prediction of antidepressant treatment response |
| Q24564427 | A phase III, double-blind, placebo-controlled, flexible-dose study of levomilnacipran extended-release in patients with major depressive disorder |
| Q51860704 | A prospective study of depression following combat deployment in support of the wars in Iraq and Afghanistan. |
| Q34172150 | A randomized, double-blind, placebo-controlled study of vortioxetine on cognitive function in depressed adults |
| Q37129835 | A review of quetiapine in combination with antidepressant therapy in patients with depression. |
| Q35561938 | A standardized protocol for repeated social defeat stress in mice. |
| Q60300920 | A supported self-help for recurrent depression in primary care; An economic evaluation alongside a multi-center randomised controlled trial |
| Q42359028 | A survey of support systems for return to work in Japanese companies: a cross-sectional study |
| Q35013687 | A team approach to systematic behavioral screening and intervention |
| Q36354501 | A twin study of depression and nicotine dependence: shared liability or causal relationship? |
| Q36061638 | A web-based approach to managing stress and mood disorders in the workforce |
| Q36860576 | ASSOCIATION BETWEEN SOCIAL MEDIA USE AND DEPRESSION AMONG U.S. YOUNG ADULTS |
| Q37349864 | Aberrant emotion networks in early major depressive disorder patients: an eigenvector centrality mapping study |
| Q28758771 | Acceptance and commitment therapy and behavioral activation for the treatment of depression: description and comparison |
| Q34505794 | Accuracy of general practitioner unassisted detection of depression |
| Q46178637 | Activating memories of depression alters the experience of voluntary action |
| Q58763210 | Adaptive School-based Implementation of CBT (ASIC): clustered-SMART for building an optimized adaptive implementation intervention to improve uptake of mental health interventions in schools |
| Q40153815 | Addressing Behavioral Health Disparities for Somali Immigrants Through Group Cognitive Behavioral Therapy Led by Community Health Workers |
| Q33658763 | Adherence and Persistence Across Antidepressant Therapeutic Classes: A Retrospective Claims Analysis Among Insured US Patients with Major Depressive Disorder (MDD). |
| Q35205431 | Adherence and persistence with branded antidepressants and generic SSRIs among managed care patients with major depressive disorder |
| Q38724088 | Adjunctive Brexpiprazole: A Review in Major Depressive Disorder |
| Q47876654 | Adjuvant thiamine improved standard treatment in patients with major depressive disorder: results from a randomized, double-blind, and placebo-controlled clinical trial. |
| Q38349600 | Adolescent-Onset Depression: Are Obesity and Inflammation Developmental Mechanisms or Outcomes? |
| Q34485868 | Adult depression screening in Saudi primary care: prevalence, instrument and cost |
| Q37281016 | Age 26 cost-benefit analysis of the child-parent center early education program |
| Q30372214 | Alterations in leukocyte transcriptional control pathway activity associated with major depressive disorder and antidepressant treatment. |
| Q34254887 | Altered expression of synapse and glutamate related genes in post-mortem hippocampus of depressed subjects |
| Q37150743 | Analysis of the effects of depression associated polymorphisms on the activity of the BICC1 promoter in amygdala neurones |
| Q31141332 | Analysis of treatment patterns and persistence on branded and generic medications in major depressive disorder using retrospective claims data |
| Q84571275 | Antidepressant adequacy and work status among medicaid enrollees with disabilities: a restriction-based, propensity score-adjusted analysis |
| Q28487260 | Antidepressant treatment outcome depends on the quality of the living environment: a pre-clinical investigation in mice |
| Q33557520 | Antidepressant- and anxiolytic effects of the novel melatonin agonist Neu-P11 in rodent models |
| Q35593084 | Antidepressant-like effect induced by systemic and intra-hippocampal administration of DNA methylation inhibitors. |
| Q35643858 | Antidepression medication improves quality of life in elderly patients with benign prostatic hyperplasia and depression |
| Q35678167 | Anxiety among community-dwelling U.S. Chinese older adults |
| Q35955663 | Are early-onset cannabis smokers at an increased risk of depression spells? |
| Q36718601 | Assessing the comparative-effectiveness of antidepressants commonly prescribed for depression in the US Medicare population |
| Q36051543 | Assessment of anxiety and depression in primary care: value of a four-item questionnaire |
| Q42370488 | Association between baseline psychological attributes and mental health outcomes after soldiers returned from deployment |
| Q37226989 | Association between severity of depression and self-perceived cognitive difficulties among full-time employees |
| Q33987958 | Association of depression and anxiety alone and in combination with chronic musculoskeletal pain in primary care patients |
| Q36281543 | Association of periodontal health indicators and major depressive disorder in hospital outpatients |
| Q35572262 | Associations between vitamin D levels and depressive symptoms in healthy young adult women |
| Q34933058 | Asthma and Mood Disorders. |
| Q36070157 | Attention bias modification for major depressive disorder: Effects on attention bias, resting state connectivity, and symptom change. |
| Q39066474 | Attention bias towards negative emotional information and its relationship with daily worry in the context of acute stress: An eye-tracking study |
| Q39435527 | Augmentation therapy with alpha-lipoic acid and desvenlafaxine: a future target for treatment of depression? |
| Q37062552 | Augmentation treatment in major depressive disorder: focus on aripiprazole |
| Q34403107 | Barriers to care and service satisfaction following homicide loss: associations with mental health outcomes |
| Q33837076 | Behavioural activation by mental health nurses for late-life depression in primary care: a randomized controlled trial |
| Q34024116 | Beyond symptomatic improvement:assessing real-world outcomes in patients with major depressive disorder |
| Q28752373 | Bilateral epidural prefrontal cortical stimulation for treatment-resistant depression |
| Q34247513 | Biomarkers to predict antidepressant response |
| Q34634227 | Boosting serotonin in the brain: is it time to revamp the treatment of depression? |
| Q37378006 | C-QUALITY: cost and quality-of-life pharmacoeconomic analysis of antidepressants used in major depressive disorder in the regional Italian settings of Veneto and Sardinia |
| Q39825160 | CHRONICITY OF DEPRESSION AND MOLECULAR MARKERS IN A LARGE SAMPLE OF HAN CHINESE WOMEN. |
| Q33900870 | Can social policy influence socioeconomic disparities? Korean War GI Bill eligibility and markers of depression |
| Q35072667 | Cancer family caregiver depression: are religion-related variables important? |
| Q26782997 | Challenging Treatment-Resistant Major Depressive Disorder: A Roadmap for Improved Therapeutics |
| Q37315816 | Change in psychosocial functioning and depressive symptoms during acute-phase cognitive therapy for depression |
| Q37626797 | Changes in physician antipsychotic prescribing preferences, 2002-2007. |
| Q28534539 | Characterization of treatment resistant depression episodes in a cohort of patients from a US commercial claims database |
| Q33732067 | Child maltreatment moderates the association of MAOA with symptoms of depression and antisocial personality disorder |
| Q36177719 | Children of mentally ill parents-a pilot study of a group intervention program |
| Q36157354 | Chronic low dose ovine corticotropin releasing factor or urocortin II into the rostral dorsal raphe alters exploratory behavior and serotonergic gene expression in specific subregions of the dorsal raphe |
| Q51729551 | Clinical consequences and economic costs of untreated obstructive sleep apnea syndrome. |
| Q36979572 | Clinician burden and depression treatment: disentangling patient- and clinician-level effects of medical comorbidity |
| Q58102444 | Close relationships and depression: A developmental cascade approach |
| Q64093961 | Cluster randomised controlled trial of a guided self-help mental health intervention in primary care |
| Q35946064 | Cognition in mania and depression: psychological models and clinical implications |
| Q34998313 | Cognitive evolutionary therapy for depression: a case study |
| Q26775386 | Cognitive remission: a novel objective for the treatment of major depression? |
| Q37266134 | Cognitive therapy versus medication for depression: treatment outcomes and neural mechanisms |
| Q35963071 | Combination use of Beck Depression Inventory and two-question case-finding instrument as a screening tool for depression in the workplace |
| Q36713430 | Combination/augmentation strategies for improving the treatment of depression. |
| Q36275914 | Communal bereavement and resilience in the aftermath of a terrorist event: Evidence from a natural experiment |
| Q41639887 | Comorbid anxiety increases cognitive control activation in Major Depressive Disorder |
| Q34729142 | Comparative effectiveness of cognitive and dynamic therapies for major depressive disorder in a community mental health setting: study protocol for a randomized non-inferiority trial |
| Q26779632 | Comparative efficacy and acceptability of first-generation and second-generation antidepressants in the acute treatment of major depression: protocol for a network meta-analysis |
| Q34664591 | Comparative efficacy of escitalopram in the treatment of major depressive disorder |
| Q33995208 | Comparative efficacy of the Cognitive Behavioral Analysis System of Psychotherapy versus supportive psychotherapy for early onset chronic depression: design and rationale of a multisite randomized controlled trial |
| Q33932339 | Comparing treatment persistence, healthcare resource utilization, and costs in adult patients with major depressive disorder treated with escitalopram or citalopram |
| Q35251978 | Cost of depression among adults in Japan |
| Q35252145 | Cost of illness and comorbidities in adults diagnosed with attention-deficit/hyperactivity disorder: a retrospective analysis |
| Q39100844 | Cost-benefit analysis of a preventive intervention for divorced families: reduction in mental health and justice system service use costs 15 years later |
| Q36603437 | Cost-effectiveness evaluation of escitalopram in major depressive disorder in Italy |
| Q48035843 | Cost-effectiveness of In-Home Cognitive Behavioral Therapy for low-income depressed mothers participating in early childhood prevention programs |
| Q34268268 | Cost-effectiveness of family psychoeducation to prevent relapse in major depression: results from a randomized controlled trial |
| Q34439498 | Cost-effectiveness of problem-solving treatment in comparison with usual care for primary care patients with mental health problems: a randomized trial |
| Q36581690 | Cost-of-illness studies : a review of current methods. |
| Q34464455 | Costs and savings associated with community water fluoridation programs in Colorado. |
| Q35795954 | Course of major depressive disorder and labor market outcome disruption. |
| Q48039679 | Creatine Prevents Corticosterone-Induced Reduction in Hippocampal Proliferation and Differentiation: Possible Implication for Its Antidepressant Effect |
| Q38009679 | Cross-cultural aspects of depression management in primary care |
| Q92897529 | Defeating Depression: The Healing Power of the Therapeutic Relationship |
| Q37713660 | Defining and measuring functional recovery from depression |
| Q30466260 | Depressed mood enhances anxiety to unpredictable threat. |
| Q35038743 | Depression and employment status in primary and tertiary care settings |
| Q28391244 | Depression and heart rate variability in firefighters |
| Q36741666 | Depression and retirement in late middle-aged U.S. workers |
| Q34009917 | Depression and the workplace: a progress report |
| Q37634525 | Depression and treatment response: dynamic interplay of signaling pathways and altered neural processes |
| Q91829194 | Depression in the South African workplace |
| Q38786565 | Depression severity and concentration difficulties are independently associated with HRQOL in patients with unipolar depressive disorders |
| Q36165095 | Depression treatment with duloxetine and reduction of inability to work |
| Q48138170 | Depression, quality of life and primary care: a cross-sectional study. |
| Q36295087 | Depressive Symptoms and Behavior-Related Risk Factors, Italian Population-Based Surveillance System, 2013 |
| Q36731712 | Depressive and cardiovascular disease comorbidity in a rat model of social stress: a putative role for corticotropin-releasing factor |
| Q36983107 | Depressive symptom trajectories among girls in the juvenile justice system: 24-month outcomes of an RCT of Multidimensional Treatment Foster Care |
| Q44883661 | Depressive symptomatology and mental health help-seeking patterns of U.S.- and foreign-born mothers |
| Q33889048 | Design and synthesis of 4-heteroaryl 1,2,3,4-tetrahydroisoquinolines as triple reuptake inhibitors |
| Q37565504 | Determinants of direct cost differences among US employees with major depressive disorders using antidepressants |
| Q36482594 | Development of a brief mental health screen for intimate partner violence victims in the emergency department |
| Q33727204 | Developmental cascade models of a parenting-focused program for divorced families on mental health problems and substance use in emerging adulthood |
| Q35777973 | Diabetes, minor depression and health care utilization and expenditures: a retrospective database study |
| Q43720293 | Diagnosis of depression and use of antidepressant pharmacotherapy among adults in the United States: does a disparity persist by ethnicity/race? |
| Q37246304 | Diagnostic Accuracy of the Primary Care Screener for Affective Disorder (PC-SAD) in Primary Care |
| Q37307139 | Differences in medical care expenditures for adults with depression compared to adults with major chronic conditions. |
| Q46327840 | Differences in medication adherence and healthcare resource utilization patterns: older versus newer antidepressant agents in patients with depression and/or anxiety disorders. |
| Q36990201 | Differences in the clinical recognition of depression in diabetes patients: the Diabetes Study of Northern California (DISTANCE) |
| Q35606958 | Differential hippocampal gene expression and pathway analysis in an etiology-based mouse model of major depressive disorder. |
| Q36410102 | Distinct but overlapping neural networks subserve depression and insecure attachment |
| Q37872289 | Do productivity costs matter?: the impact of including productivity costs on the incremental costs of interventions targeted at depressive disorders |
| Q57126501 | Doctoral students' well-being: a literature review |
| Q37709599 | Does long-term experience of nonstandard employment increase the incidence of depression in the elderly? |
| Q37173825 | Duloxetine hepatotoxicity: a case-series from the drug-induced liver injury network. |
| Q36853538 | Duloxetine: a review of its use in the treatment of major depressive disorder |
| Q36672130 | Dyad of pain and depression in chronic rhinosinusitis |
| Q48881124 | Economic burden of depression in South Korea. |
| Q36128777 | Economic considerations in the prescribing of third-generation antidepressants |
| Q45944932 | Economic costs of depression in China. |
| Q33445389 | Effectiveness and cost-effectiveness of an exposure-based return-to-work programme for patients on sick leave due to common mental disorders: design of a cluster-randomized controlled trial |
| Q38373849 | Effectiveness of a Web-Based Intervention in Reducing Depression and Sickness Absence: Randomized Controlled Trial. |
| Q33694937 | Effectiveness of adjuvant occupational therapy in employees with depression: design of a randomized controlled trial |
| Q90231441 | Effectiveness of an internet-based self-guided program to treat depression in a sample of Brazilian users: a study protocol |
| Q24288917 | Effectiveness of antidepressants: an evidence myth constructed from a thousand randomized trials? |
| Q51756612 | Effects of Iraq/Afghanistan deployments on major depression and substance use disorder: analysis of active duty personnel in the US military. |
| Q38923342 | Effects of Perceived Discrimination on Depressive Symptoms Among Black Men Residing in the United States: A Meta-Analysis |
| Q47393480 | Effects of depression, metabolic syndrome, and cardiorespiratory fitness on mortality: results from the Cooper Center Longitudinal Study |
| Q90124623 | Effects of repeated voluntary or forced exercise on brainstem serotonergic systems in rats |
| Q64982663 | Efficacy and acceptability of adjunctive psychological and pharmacological interventions for treatment-resistant depression: protocol for a systematic review and network meta-analysis. |
| Q92978907 | Efficacy and safety of oral SOCG in treatment of major depressive disorder: A protocol for a phase II, randomized, double-blind, placebo controlled, parallel-groups, dose finding exploratory study |
| Q59807356 | Efficacy of light therapy on nonseasonal depression among elderly adults: a systematic review and meta-analysis |
| Q34644729 | Efficacy of peer support interventions for depression: a meta-analysis |
| Q34122946 | Emerging treatments in the management of bipolar disorder - focus on risperidone long acting injection. |
| Q45338982 | Emotional support, negative interaction and major depressive disorder among African Americans and Caribbean Blacks: findings from the National Survey of American Life |
| Q36406654 | Epidemiological study of the prevalence of depressive disorders in primary health care in Morocco |
| Q34778675 | Epidemiology of major depressive disorder in mainland china: a systematic review |
| Q34864481 | Epigenetic mechanisms underlying the role of brain-derived neurotrophic factor in depression and response to antidepressants. |
| Q36675639 | Epigenetic regulation of RAC1 induces synaptic remodeling in stress disorders and depression |
| Q33375445 | Escitalopram and duloxetine in major depressive disorder: a pharmacoeconomic comparison using UK cost data |
| Q47399076 | Estimating Prevalence and Healthcare Utilization for Treatment-Resistant Depression in Japan: A Retrospective Claims Database Study |
| Q35776341 | Evaluation of periodontitis in hospital outpatients with major depressive disorder |
| Q36904522 | Evidence for IL-1 receptor blockade as a therapeutic strategy for the treatment of depression |
| Q35667964 | Examining antidepressant drug response by smoking status: why is it important and how often is it done? |
| Q35223243 | Expectations among patients and health professionals regarding Web-based interventions for depression in primary care: a qualitative study |
| Q34111309 | Expenditures associated with dose titration at initiation of therapy in patients with major depressive disorder: a retrospective analysis of a large managed care claims database. |
| Q37732228 | Feeling blue or turquoise? Emotional differentiation in major depressive disorder |
| Q36952306 | Financial Dependence of Young Adults with Childhood ADHD. |
| Q24236814 | Fluvoxamine versus other anti-depressive agents for depression |
| Q37735473 | From stress to inflammation and major depressive disorder: a social signal transduction theory of depression |
| Q34565649 | Frontocingulate dysfunction in depression: toward biomarkers of treatment response |
| Q64065377 | Fusing Mobile Phone Sensing and Brain Imaging to Assess Depression in College Students |
| Q37336702 | Future Antidepressant Targets: Neurotrophic Factors and Related Signaling Cascades |
| Q58708254 | Genetic Modulation at the Neural Microelectrode Interface: Methods and Applications |
| Q28265155 | Genetics of smoking and depression |
| Q28384381 | Genome-wide linkage on chromosome 10q26 for a dimensional scale of major depression |
| Q64984270 | Girls' internalizing symptoms and white matter tracts in Cortico-Limbic circuitry. |
| Q37402277 | Global patterns of workplace productivity for people with depression: absenteeism and presenteeism costs across eight diverse countries. |
| Q44961117 | Health care providers' perspectives of medication adherence in the treatment of depression: a qualitative study |
| Q36402948 | How Should We Screen Patients for Major Depression? |
| Q38014710 | How should primary care doctors select which antidepressants to administer? |
| Q33607686 | Immediate Mood Scaler: Tracking Symptoms of Depression and Anxiety Using a Novel Mobile Mood Scale |
| Q35762585 | Impact of a work-focused intervention on the productivity and symptoms of employees with depression |
| Q34925015 | Impaired prefronto-thalamic functional connectivity as a key feature of treatment-resistant depression: a combined MEG, PET and rTMS study |
| Q30663882 | Implementing measurement-based care (iMBC) for depression in community mental health: a dynamic cluster randomized trial study protocol |
| Q40164828 | Improving Quality of Emergency Care Through Integration of Mental Health |
| Q33576322 | Improving the effectiveness of sickness benefit case management through a public-private partnership? A difference-in-difference analysis in eighteen Danish municipalities |
| Q34115025 | Inclusion of women and gender-specific analyses in randomized clinical trials of treatments for depression |
| Q27305254 | Increased Signaling via Adenosine A1 Receptors, Sleep Deprivation, Imipramine, and Ketamine Inhibit Depressive-like Behavior via Induction of Homer1a |
| Q35023431 | Inflammation, obesity, and metabolic syndrome in depression: analysis of the 2009-2010 National Health and Nutrition Examination Survey (NHANES) |
| Q36926937 | Influences of biological and adoptive mothers' depression and antisocial behavior on adoptees' early behavior trajectories. |
| Q36900311 | Integrated care of an aging HIV-infected male-to-female transgender patient |
| Q36631419 | Integrated care: treatment initiation following positive depression screens. |
| Q34673125 | Internet-based depression prevention over the life course: a call for behavioral vaccines |
| Q33678055 | Internet-delivered treatment: its potential as a low-intensity community intervention for adults with symptoms of depression: protocol for a randomized controlled trial |
| Q36201294 | Is early intervention for psychosis feasible and effective? |
| Q34722818 | Job performance deficits due to depression |
| Q35193945 | Job strain, depressive symptoms, and drinking behavior among older adults: results from the health and retirement study |
| Q34560916 | Lack of exercise is a major cause of chronic diseases |
| Q26995710 | Late life depression: a global problem with few resources |
| Q36199796 | Long-term effects of mental disorders on employment in the National Comorbidity Survey ten-year follow-up |
| Q34989517 | Longitudinal Associations Between Husbands' and Wives' Depressive Symptoms |
| Q35284412 | Major depressive disorder: mechanism-based prescribing for personalized medicine |
| Q33576106 | Managing Depressive Symptoms in the Workplace Using a Web-Based Self-Care Tool: A Pilot Randomized Controlled Trial |
| Q48061720 | Maternal Depression Is Related to Reduced Error-Related Brain Activity in Child and Adolescent Offspring |
| Q36558223 | Medical costs and utilization in patients with depression treated with adjunctive atypical antipsychotic therapy |
| Q28073097 | Men, Work, and Mental Health: A Systematic Review of Depression in Male-dominated Industries and Occupations |
| Q26771675 | Mental Health Interventions in the Workplace and Work Outcomes: A Best-Evidence Synthesis of Systematic Reviews |
| Q34311132 | Mental distress and service utilization among help-seeking, community-dwelling older adults |
| Q37114076 | Mental health and the workplace: issues for developing countries |
| Q53449700 | Mental health burden in a national sample of American Indian and Alaska Native adults: differences between multiple-race and single-race subgroups. |
| Q36626338 | Mental health of aging immigrants and native-born men across 11 European countries |
| Q34034522 | Mental health service utilization after physical trauma: the importance of physician referral |
| Q24240125 | Milnacipran versus other antidepressive agents for depression |
| Q37718568 | Misdiagnosed hypomanic symptoms in patients with treatment-resistant major depressive disorder in Italy: results from the improve study |
| Q31077469 | Missing clinical and behavioral health data in a large electronic health record (EHR) system |
| Q61449989 | Mitochondria, Microglia, and the Immune System-How Are They Linked in Affective Disorders? |
| Q34361887 | Modeling the dynamics of disease states in depression. |
| Q38086422 | Molecular Neurobiology of Depression: PET Findings on the Elusive Correlation with Symptom Severity |
| Q30502895 | Mood-linked responses in medial prefrontal cortex predict relapse in patients with recurrent unipolar depression |
| Q38999019 | Multidimensional prediction of treatment response to antidepressants with cognitive control and functional MRI. |
| Q92859477 | Neural Recording and Modulation Technologies |
| Q34517902 | Neurobiological alterations induced by exercise and their impact on depressive disorders [corrected]. |
| Q39311440 | Neurobiological mechanisms of stress resilience and implications for the aged population. |
| Q37432089 | Neuroinflammation and comorbidity of pain and depression |
| Q27023810 | Neuromodulation for mood and memory: from the engineering bench to the patient bedside |
| Q35632709 | No evidence of non-homologous insertions in mouse model of MDD created by replacement of homologous mouse DNA sequence with pathogenic 6-base human CREB1 promoter sequence |
| Q34556556 | Nonhuman primate models of depression: effects of early experience and stress |
| Q33664173 | Nuclear factor-kappaB is a critical mediator of stress-impaired neurogenesis and depressive behavior |
| Q36034152 | Omega-3 fatty acid augmentation of citalopram treatment for patients with major depressive disorder. |
| Q33618118 | Online cognitive behavioral therapy for depressed primary care patients: a pilot feasibility project |
| Q33767182 | Open questions in current models of antidepressant action |
| Q46611952 | PERSONAL VULNERABILITIES AND ASSORTATIVE MATE SELECTION AMONG NEWLYWED SPOUSES. |
| Q34438594 | Pain and depression comorbidity: a preclinical perspective |
| Q33551755 | Parent Depression and Child Anxiety: An Overview of the Literature with Clinical Implications |
| Q36332597 | Pathogenesis of depression: Insights from human and rodent studies |
| Q37222053 | Paths of effects from preschool to adult well-being: a confirmatory analysis of the child-parent center program. |
| Q33871797 | Patterns of psychosocial risk and long-term outcomes in rheumatoid arthritis |
| Q34569403 | Peripheral blood and neuropsychological markers for the onset of action of antidepressant drugs in patients with Major Depressive Disorder |
| Q34905928 | Persistent depression and anxiety in the United States: prevalence and quality of care |
| Q55618447 | Personalised relaxation practice to improve sleep and functioning in patients with chronic fatigue syndrome and depression: study protocol for a randomised controlled trial. |
| Q47936368 | Phosphodiesterase-1b (Pde1b) knockout mice are resistant to forced swim and tail suspension induced immobility and show upregulation of Pde10a. |
| Q36377477 | Phosphoproteomic differences in major depressive disorder postmortem brains indicate effects on synaptic function |
| Q37130488 | Placental Corticotropin-Releasing Hormone Mediates the Association Between Prenatal Social Support and Postpartum Depression |
| Q37365678 | Postnatal depression in Mexican American fathers: demographic, cultural, and familial predictors |
| Q49829601 | Potential and Challenges for the Clinical Use of d-Serine As a Cognitive Enhancer. |
| Q34740489 | Potential predictors of delay in initial treatment contact after the first onset of depression in Japan: a clinical sample study |
| Q34722802 | Poverty, Material Hardship and Depression |
| Q36382946 | Preclinical and clinical characterization of the selective 5-HT(1A) receptor antagonist DU-125530 for antidepressant treatment |
| Q35986258 | Prediction of susceptibility to major depression by a model of interactions of multiple functional genetic variants and environmental factors |
| Q47838168 | Prediction of treatment outcomes to exercise in patients with nonremitted major depressive disorder. |
| Q46608297 | Predictors of Depressive Symptoms in Emerging Adulthood in a Low-Income Urban Cohort. |
| Q60908927 | Predictors of the effectiveness of an early medication change strategy in patients with major depressive disorder |
| Q35901587 | Prevalence and effects of mood disorders on work performance in a nationally representative sample of U.S. workers |
| Q34281712 | Prevalence of anxiety and depression among outpatients with type 2 diabetes in the Mexican population. |
| Q37103463 | Previous Out-of-Pocket Drug Expenditures and Patterns of Antidepressant Use among Workers Receiving Depression-Related Disability Benefits |
| Q34598190 | Prospective study of cardiorespiratory fitness and depressive symptoms in women and men |
| Q24603107 | Proteomic investigation of epigenetics in neuropsychiatric disorders: a missing link between genetics and behavior? |
| Q38266167 | Psychological approach of occupational health service to sick leave due to mental problems: a systematic review and meta-analysis |
| Q53682337 | Psychological therapies for treatment-resistant depression in adults. |
| Q40048757 | Psychometric properties of a short form of the Center for Epidemiologic Studies Depression (CES-D-10) scale for screening depressive symptoms in healthy community dwelling older adults |
| Q36995148 | Psychosocial outcomes in patients with recurrent major depressive disorder during 2 years of maintenance treatment with venlafaxine extended release |
| Q27014852 | Pupillary motility: bringing neuroscience to the psychiatry clinic of the future |
| Q34178712 | Quality Improvement in Nursing Homes: Identifying Depressed Residents is Critical to Improving Quality of Life |
| Q37191385 | Quality Over Quantity: Integrating Mental Health Assessment Tools into Primary Care Practice |
| Q40226480 | Randomized controlled trial of interpersonal psychotherapy versus enhanced treatment as usual for women with co-occurring depression and pelvic pain. |
| Q33441923 | Rasch model analysis of the Depression, Anxiety and Stress Scales (DASS). |
| Q33724051 | Rationale and design of the randomised clinical trial comparing early medication change (EMC) strategy with treatment as usual (TAU) in patients with major depressive disorder--the EMC trial |
| Q94401185 | Reboxetine versus other antidepressive agents for depression |
| Q37167833 | Recurrent major depression and right hippocampal volume: A bivariate linkage and association study |
| Q37533875 | Reducing the Burden of Difficult-to-Treat Major Depressive Disorder: Revisiting Monoamine Oxidase Inhibitor Therapy |
| Q36693787 | Reducing the societal burden of depression: a review of economic costs, quality of care and effects of treatment |
| Q34652291 | Reducing youth internalizing symptoms: effects of a family-based preventive intervention on parental guilt induction and youth cognitive style. |
| Q36165233 | Remission from depression : a review of venlafaxine clinical and economic evidence |
| Q35062660 | Remission with venlafaxine extended release or selective serotonin reuptake inhibitors in depressed patients: a randomized, open-label study |
| Q30547324 | Repeated ketamine exposure induces an enduring resilient phenotype in adolescent and adult rats |
| Q51999437 | Resource use and costs associated with patients treated for depression in primary care. |
| Q34245326 | Resource utilisation and costs of depressive patients in Germany: results from the primary care monitoring for depressive patients trial |
| Q36643303 | Resource utilization and costs associated with insomnia treatment in patients with major depressive disorder |
| Q30431266 | Resting frontal EEG asymmetry as an endophenotype for depression risk: Sex-specific patterns of frontal brain asymmetry |
| Q57177749 | Resting frontal brain asymmetry is linked to future depressive symptoms in women |
| Q34996777 | Retroinverso analogs of spadin display increased antidepressant effects |
| Q34911339 | Role of depression in outcomes of endoscopic sinus surgery |
| Q64073037 | Routine Assessment of Health Impacts of Local Transportation Plans: A Case Study From the City of Los Angeles |
| Q34542360 | S-adenosyl methionine (SAMe) for depression in adults. |
| Q34351135 | Screening Depression Aging Services Clients |
| Q24245591 | Screening and case finding instruments for depression |
| Q36014622 | Self-reported predictors of depressive symptomatology in an elderly population with type 2 diabetes mellitus: a prospective cohort study |
| Q37119504 | Serotonin transporter gene moderates childhood maltreatment's effects on persistent but not single-episode depression: replications and implications for resolving inconsistent results |
| Q37244807 | Serotonin transporter polymorphism predicts waking cortisol in young girls. |
| Q37283547 | Social, economic, and health utility considerations in the treatment of overactive bladder |
| Q48334746 | Specific medical conditions associated with clinically significant depressive symptoms in men. |
| Q41253442 | Spontaneous Thought and Vulnerability to Mood Disorders: The Dark Side of the Wandering Mind |
| Q34023777 | Strategies to improve the management of depression in primary care |
| Q33734177 | Stressful life events, chronic difficulties, and the symptoms of clinical depression |
| Q53814092 | Susceptibility to chronic social stress increases plaque progression, vulnerability and platelet activation. |
| Q30861280 | Systematic review and assessment of validated case definitions for depression in administrative data |
| Q37349893 | TLR4 signaling in VTA dopaminergic neurons regulates impulsivity through tyrosine hydroxylase modulation |
| Q36802652 | Targeted Rejection Triggers Differential Pro- and Anti-Inflammatory Gene Expression in Adolescents as a Function of Social Status |
| Q36924338 | Ten-year trends in quality of care and spending for depression: 1996 through 2005. |
| Q37585323 | The Antidepressant-like Effect of Ethanol Extract of Daylily Flowers ( Jīn Zhēn Huā) in Rats |
| Q39022647 | The Association Between Maternal Depression During Pregnancy and Adverse Birth Outcomes: A Retrospective Cohort Study of PRAMS Participants. |
| Q33843294 | The Depression Conundrum and the Advantages of Uncertainty |
| Q35617316 | The Effect of Cognitive Impairment on Mental Healthcare Costs for Individuals With Severe Psychiatric Illness |
| Q46261340 | The Effects of Collaborative Care Training on Case Managers' Perceived Depression-Related Services Delivery. |
| Q89510117 | The Relationship between DNA Methylation and Antidepressant Medications: A Systematic Review |
| Q34741960 | The STAR*D Project results: a comprehensive review of findings. |
| Q40076050 | The Upper Bavarian longitudinal community study 1975-2004. 2. Long-term course and outcome of depression. A controlled study |
| Q36334752 | The association of sleep duration and depressive symptoms in rural communities of Missouri, Tennessee, and Arkansas |
| Q93184987 | The burden of suicidal ideation across Europe: a cross-sectional survey in five countries |
| Q34811897 | The clinical research center for depression study: baseline characteristics of a korean long-term hospital-based observational collaborative prospective cohort study |
| Q36575361 | The cost-utility of maintenance treatment with venlafaxine in patients with recurrent major depressive disorder |
| Q35799226 | The costs of depression |
| Q27692061 | The depression treatment cascade in primary care: a public health perspective |
| Q41616550 | The direct healthcare costs associated with psychological distress and major depression: A population-based cohort study in Ontario, Canada. |
| Q34479419 | The economic and social burden of compulsive hoarding |
| Q46931660 | The economic impact of introducing serotonin-noradrenaline reuptake inhibitors into the Brazilian national drug formulary: cost-effectiveness and budget-impact analyses |
| Q26827659 | The effectiveness of return-to-work interventions that incorporate work-focused problem-solving skills for workers with sickness absences related to mental disorders: a systematic literature review |
| Q39792295 | The effects of attention-deficit/hyperactivity disorder on employment and household income. |
| Q33908984 | The epidemiology of depression across cultures |
| Q36079041 | The establishment of the objective diagnostic markers and personalized medical intervention in patients with major depressive disorder: rationale and protocol. |
| Q30886413 | The general and comparative efficacy and safety of duloxetine in major depressive disorder: a systematic review and meta-analysis |
| Q48708499 | The impact of psychiatric disorders on employment: results from a national survey (NESARC). |
| Q36920034 | The impact of work environment on mood disorders and suicide: Evidence and implications |
| Q33622133 | The importance of functional impairment to mental health outcomes: a case for reassessing our goals in depression treatment research |
| Q46392397 | The lipidome in major depressive disorder: Shared genetic influence for ether-phosphatidylcholines, a plasma-based phenotype related to inflammation, and disease risk |
| Q35450083 | The long-run effect of maternity leave benefits on mental health: evidence from European countries |
| Q24632666 | The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication |
| Q38569937 | The prevalence, measurement, and treatment of the cognitive dimension/domain in major depressive disorder |
| Q34772607 | The prevention of adolescent depression |
| Q35560792 | The public health impact of major depression: a call for interdisciplinary prevention efforts |
| Q35607908 | The relationship of deiodinase 1 genotype and thyroid function to lifetime history of major depression in three independent populations |
| Q50750012 | The role of depression in short-term mood and fatigue responses to acute exercise. |
| Q30251744 | The role of vitamin D in the prevention of late-life depression |
| Q37086346 | The trajectory of depressive symptoms across the adult life span |
| Q87681760 | Time-Frequency Reward-Related Delta Prospectively Predicts the Development of Adolescent-Onset Depression |
| Q36874237 | Translating comparative effectiveness of depression medications into practice by comparing the depression medication choice decision aid to usual care: study protocol for a randomized controlled trial |
| Q42699422 | UArizona at the CLEF eRisk 2017 Pilot Task: Linear and Recurrent Models for Early Depression Detection |
| Q34820550 | Unemployment, job retention, and productivity loss among employees with depression |
| Q44694449 | Union perceptions of factors related to the return to work of employees with depression |
| Q60954117 | University⁻Community Partnerships Using a Participatory Action Research Model to Evaluate the Impact of Dance for Health |
| Q83920837 | Use of depression education materials to improve treatment compliance of primary care patients |
| Q34093013 | Use of the varying coefficient model in an exercise and depression meta-analysis |
| Q55155452 | Using Social Cognitive Theory to Predict Medication Compliance Behavior in Patients with Depression in Southern United States in 2016 in a Cross-Sectional Study. |
| Q33452067 | Using a smartphone app to reduce cognitive vulnerability and mild depressive symptoms: Study protocol of an exploratory randomized controlled trial |
| Q37542032 | Validity Assessment of 5 Day Repeated Forced-Swim Stress to Model Human Depression in Young-Adult C57BL/6J and BALB/cJ Mice |
| Q38783703 | Variation in Major Depressive Disorder Onset by Place of Origin Among U.S. Latinos |
| Q37487739 | Venlafaxine ameliorates the depression-like behaviors and hippocampal S100B expression in a rat depression model |
| Q28083651 | Vilazodone for the treatment of major depressive disorder: an evidence-based review of its place in therapy |
| Q37514703 | Vilazodone in the treatment of major depressive disorder: efficacy across symptoms and severity of depression |
| Q60106514 | Voluntary wheel running promotes resilience to chronic social defeat stress in mice: a role for nucleus accumbens ΔFosB |
| Q37651782 | We are the hollow men: The worldwide epidemic of mental illness, psychiatric and behavioral emergencies, and its impact on patients and providers |
| Q51860911 | What are the predictors of work impairment in Iranian patients with depressive disorders? |
| Q37715559 | What happens next?: a claims database study of second-line pharmacotherapy in patients with major depressive disorder (MDD) who initiate selective serotonin reuptake inhibitor (SSRI) treatment |
| Q42967923 | When could a stigma program to address mental illness in the workplace break even? |
| Q81436865 | [Innovative care models for treating depression] |
| Q42417207 | iSPOT-D Trial Has Potential To Personalize Antidepressant Treatment |
Search more.